| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 322,494 | 363,139 | 367,463 | 768,928 | | Cost of Revenue | 204,872 | 303,506 | 316,434 | 719,836 | | | Gross Profit | 117,622 | 59,633 | 51,029 | 49,092 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 100,631 | 14,882 | 14,859 | 22,751 | | Non Recurring |
-
| (431) | (5,214) | 26,302 | | Others | 25,529 | 33,767 | 31,584 | 34,279 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,561) | 11,415 | 9,800 | (34,240) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,242 | 185 | (4,690) | 61,586 | | Earnings Before Interest And Taxes | (70,773) | 11,600 | 5,110 | 12,598 | | Interest Expense | (48,400) | 26,111 | 22,289 | 74,976 | | Income Before Tax | (22,373) | (14,511) | (17,179) | (62,378) | | Income Tax Expense | (3,123) | (1,689) | 2,406 | (8,321) | | Minority Interest |
-
|
-
|
-
| 38,313 | | | | Net Income From Continuing Ops | (19,250) | (12,822) | (19,585) | (15,744) | | | Non-recurring Events | | Discontinued Operations | 83,588 | 3,513 | 1,538 | 11,279 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,894 | (9,309) | (18,047) | (4,465) | | Preferred Stock And Other Adjustments | (15,428) | 6,223 | 9,205 |
-
| | | Net Income Applicable To Common Shares | $15,466 | ($3,086) | ($8,842) | ($4,465) |
|
0.51% Nasdaq 
Income Statement
